About
Thea Anine Strøm Halden
Position: PhD
Place of work: Department of Transplant Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet / University of Oslo
E-mail: t.a.s.halden@medisin.uio.no
Phone: +47 41 62 35 02
Current research focus
My Research Field is Post-Transplantation Diabetes Mellitus (PTDM). Renal transplant recipients die prematurely due to cardiovascular disease and PTDM is a pivotal risk factor in the cardiovascular risk of these patients. It is therefore major focus on finding ways to prevent and reduce this risk.
Oslo University Hospital Rikshospitalet has one of the worlds largest single center cohorts of renal transplant recipients that enables well-controlled studies to be performed. The PhD project aims to have clinical impact on the treatment of renal transplant recipients, e.g. better understanding of the origin (insulin/glucagon balance) and impact of hyperglycemia in organ transplanted patients, as well as optimal treatment of PTDM.
Publications
Halden, T. A. S., K. E. Kvitne, K. Midtvedt, L. Rajakumar, I. Robertsen, J. Brox, J. Bollerslev, et al. "Efficacy and Safety of Empagliflozin in Renal Transplant Recipients with Posttransplant Diabetes Mellitus." [In eng]. Diabetes Care 42, no. 6 (Jun 2019): 1067-74. https://doi.org/10.2337/dc19-0093.
Ussif, A. M., A. Åsberg, T. A. S. Halden, E. Nordheim, A. Hartmann, and T. Jenssen. "Validation of Diagnostic Utility of Fasting Plasma Glucose and Hba1c in Stable Renal Transplant Recipients One Year after Transplantation." [In eng]. BMC Nephrol 20, no. 1 (Jan 10 2019): 12. https://doi.org/10.1186/s12882-018-1171-3.
Eide, I. A., T. A. S. Halden, A. Hartmann, D. O. Dahle, A. Åsberg, and T. Jenssen. "Associations between Posttransplantation Diabetes Mellitus and Renal Graft Survival." [In eng]. Transplantation 101, no. 6 (Jun 2017): 1282-89. https://doi.org/10.1097/tp.0000000000001259.
Eide, I. A., T. A. Halden, A. Hartmann, A. Åsberg, D. O. Dahle, A. V. Reisaeter, and T. Jenssen. "Mortality Risk in Post-Transplantation Diabetes Mellitus Based on Glucose and Hba1c Diagnostic Criteria." [In eng]. Transpl Int 29, no. 5 (May 2016): 568-78. https://doi.org/10.1111/tri.12757.
Eide, I. A., T. A. Halden, A. Hartmann, A. Åsberg, D. O. Dahle, A. V. Reisæter, and T. Jenssen. "Limitations of Hemoglobin A1c for the Diagnosis of Posttransplant Diabetes Mellitus." [In eng]. Transplantation 99, no. 3 (Mar 2015): 629-35. https://doi.org/10.1097/tp.0000000000000376.
Eide, I. A., T. A. Halden, and T. Jenssen. "The Authors' Reply: Hba1c Is Insensitive at Month 3 after Kidney Transplantation." [In eng]. Transplantation 99, no. 5 (May 2015): e38. https://doi.org/10.1097/tp.0000000000000684.
Strøm Halden, T. A., A. Åsberg, K. Vik, A. Hartmann, and T. Jenssen. "Short-Term Efficacy and Safety of Sitagliptin Treatment in Long-Term Stable Renal Recipients with New-Onset Diabetes after Transplantation." [In eng]. Nephrol Dial Transplant 29, no. 4 (Apr 2014): 926-33. https://doi.org/10.1093/ndt/gft536.